-
Lynn F. Reinke, PhD, ATSF, Awarded the American Thoracic Society’s 2026 J. Randall Curtis Humanism Award for Promoting Respiratory Health
The American Thoracic Society is proud to announce that Lynn F. Reinke, PhD, ATSF, has received the J. Randall Curtis Humanism Award. This award celebrates her outstanding work at the University of Utah.- May 18, 2026
-
Dr. Tyra Bryant-Stephens Awarded the American Thoracic Society 2026 Public Service Award for Promoting Respiratory Health
The American Thoracic Society is proud to announce that Tyra Bryant-Stephens, MD, has received a 2026 Public Service Award. This honor celebrates her outstanding work at Children’s Hospital of Philadelphia.- May 14, 2026
-
Once-Nightly Pill Treats Causes of Airway Collapse to Control OSA
A once-nightly oral pill helped control obstructive sleep apnea in a large, phase 3 clinical trial presented at the 2026 ATS International Conference.- May 13, 2026
-
ATS NOW: A New On-Demand Learning Platform Launches Today
The American Thoracic Society expanded access to its educational content, leveraging AI to bring personalized learning to pulmonary, critical care and sleep medicine professionals.- May 13, 2026
-
Public Housing Mold Intervention Program Reduces Asthma-Related ED Visits
The New York City Housing Authority developed Mold Busters, a mold-removal program, in response to a 2013 class-action lawsuit filed by residents suffering from asthma due to mold in their apartments. New research presented at the ATS 2026 International Conference shows that the program results in nearly 2,800 fewer asthma-related emergency department visits annually.- May 06, 2026
-
Pediatric Pulmonary Rehab Improves Exercise Ability, Quality of Life
New research presented at the 2026 ATS International Conference shows that pulmonary rehabilitation (PR) significantly improves functioning and quality of life in children with chronic respiratory conditions, regardless of whether lung function itself improves.- May 06, 2026
-
Study Quantifies the Staggering Economic Toll of TB
The impacts of tuberculosis (TB) are usually discussed in terms of public health and human suffering. Now, new research presented at the 2026 ATS International Conference shows that TB is also driving a massive global economic crisis.- May 06, 2026
-
Tezepelumab Controls Asthma in Diverse Patient Population
The drug tezepelumab was shown to significantly reduce exacerbations in people with severe asthma in clinical trials. Now, a new study presented at the 2026 ATS International Conference shows that it is also safe and effective in real-world patients. “Tezepelumab in Real-World U.S. Patients with Severe Asthma Across Phenotypes and Underrepresented Populations: The Phase 4 PASSAGE Study” will be published in the American Journal of Respiratory and Critical Care Medicine online on May 18.- May 06, 2026
-
Access to Anti-Inflammatory Inhalers for Everyone with Asthma – Still an Urgent Need
American Thoracic Society Joins FIRS Partners in this Call for Action on World Asthma Day- May 01, 2026
-
American Thoracic Society Announces Landmark Initiative to Improve Diagnosis of Bronchiectasis Across the United States
Major quality improvement study spanning seven academic medical systems aims to address widespread underdiagnosis of bronchiectasis, a serious and underrecognized lung disease, with support from Insmed Incorporated.- Apr 29, 2026
Press Releases
All the latest news from the American Thoracic Society